New approaches to assessing the effects of mutagenic agents on the integrity of the human genome

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 616, Issue 1-2, 2007, Pages 83-89

  Elespuru, R K ^a   Sankaranarayanan, K ^b  

^a Division of Biology   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Environmental mutagenesis; Germ cell mutagenesis; Heritable alterations; Human genetic disease; Integrity of the genome; Molecular epidemiology

Indexed keywords

ENVIRONMENTAL MUTAGEN; MUTAGENIC AGENT;

ARTICLE; BIRTH DEFECT; DNA DAMAGE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC SCREENING; GENOMIC INSTABILITY; HEALTH HAZARD; HUMAN; HUMAN GENOME; IONIZING RADIATION; MOLECULAR EPIDEMIOLOGY; MUTAGENESIS; PRIORITY JOURNAL; RADIATION EXPOSURE; REGISTER;

ABNORMALITIES; ENVIRONMENTAL POLLUTANTS; FORECASTING; GENETIC DISEASES, INBORN; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOMIC INSTABILITY; GERM CELLS; GERM-LINE MUTATION; HUMANS; MUTAGENS; REGISTRIES; RISK ASSESSMENT;

EID: 33846804427     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2006.11.015     Document Type: Article

References (77)

1. Muller H.J. Artificial transmutation of the gene. Science 66 (1927) 84-87
2. Auerbach C., Robson J.M., and Carr J.G. The chemical production of mutations. Science 105 (1947) 243-247
3. Malling H.V. History of the science of mutagenesis from a personal perspective. Environ. Mol. Mutagen. 44 (2004) 372-386
4. Bridges B.A. Mechanisms of radiation mutagenesis in cellular and subcellular systems. Annu. Rev. Nucl. Sci. 19 (1969) 139-178
5. Auerbach C., and Kilbey B.J. Mutation in eukaryotes. Ann. Rev. Genet. 5 (1971)
6. McCann J., Choi E., Yamasaki E., and Ames B.N. Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. Proc. Natl. Acad. Sci. U.S.A. 72 (1975) 5135-5139
7. Carrano A.V. Induction of chromosomal aberrations in human lymphocytes by X-rays and fission neutrons: dependence on cell cycle stage. Radiat. Res. 63 (1975) 403-421
8. O'Neill J.P., Couch D.B., Machanoff R., San Sebastian J.R., Brimer P.A., and Hsie A.W. A quantitative assay of mutation induction at the hypoxanthine-guanine phosphoribosyl transferase locus in Chinese hamster ovary cells (CHO/HGPRT system): utilization with a variety of mutagenic agents. Mutat. Res. 45 (1977) 103-109
9. Russell W.L. X-ray-induced mutations in mice. Cold Spring Harbor Symp. Quant. Biol. 16 (1951) 327-336
10. Searle A.G. Mutation induction in mice. Adv. Rad. Biol. 4 (1974) 131-207
11. Cox B.D., and Lyon M.F. X-ray induced dominant lethal mutations in mature and immature oocytes of guinea-pigs and golden hamsters. Mutat. Res. 28 (1975) 421-436
12. Ehling U.H. Comparison of the mutagenic effects of chemicals and ionizing radiation in germ cells of the mouse. In: Alacevic M. (Ed). Environmental Mutagenesis (1980), Elsevier/North-Holland, Amsterdam 47-58
13. Adler I.D. Comparison of types of chemically induced genetic changes in mammals. Mutat. Res. 115 (1983) 293-321
14. Nomura T. X-ray and chemically induced germline mutations causing phenotypic abnormalities in mice. Mutat. Res. 198 (1988) 309-320
15. Russell L.B. Factors that affect the molecular nature of germ-line mutations recovered in the mouse specific-locus test. Environ. Mol. Mutagen. 18 (1991) 298-302
16. Shelby M.D. Selecting chemicals and assays for assessing mammalian germ cell mutagenicity. Mutat. Res. 352 (1996) 159-167
17. Plummer G. Anomalies occurring in children exposed in utero to the atomic bomb in Hiroshima. Pediatrics 10 (1952) 687-693
18. Otake M., Schull W.L., and Neel J.V. Congenital malformations, stillbirths and early mortality among the children of atomic bomb survivors. Radiat. Res. 122 (1990) 1-11
19. In: Neel J.V., and Schull W.J. (Eds). The Children of Atomic Bomb Survivors: A Genetic Study (1991), National Academy Press, Washington, D.C
20. Czeizel A., et al. The evaluation of the germinal mutagenic impact of Chernobyl radiological contamination in Hungary. Mutagenesis 6 (1991) 285-288
21. Little J. The Chernobyl accident, congenital anomalies and other reproductive outcomes. Paediatr. Perinat. Epidemiol. 7 (1993) 121-151
22. Byrne J., et al. Genetic disease in offspring of long-term survivors of childhood and adolescent cancer. Am. J. Hum. Genet. 62 (1998) 45-52
23. Boice Jr. J.D., et al. Genetic effects of radiotherapy for childhood cancer. Health Phys. 85 (2003) 65-80
24. United Nations Scientific Committee on the Effects of Atomic Radiation Hereditary Effects of Radiation: Unscear 2001 Report to the General Assembly, with Scientific Annex. United Nations Publications, 2003, pp. 1-160.
25. Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation (2005), National Academy Press, National Research Council, BEIR VII Phase 2 pp.1-750
26. ICPEMC, International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC Working Paper 5/6
27. Mulvihill J.J., and Czeizel A. Perspectives in mutation epidemiology, 6. A 1983 view of sentinel phenotypes. Mutat. Res. 123 (1983) 345-361
28. Rinchik E.M., and Russell L.B. Germ-line deletion mutations in the mouse: tools for intensive functional and physical mapping of regions of the mammalian genome. In: Davies K.E., and Tilghman S.M. (Eds). Genome Analysis: Genetic and Physical Mapping vol. 1 (1990), Cold Spring Harbor Laboratory Press, New York 121-158
29. Thacker J. Radiation-induced mutations in mammalian cells at low doses and dose-rates. Adv. Radiat. Biol. 16 (1992) 77-124
30. Sankaranarayanan K. Ionizing radiation and genetic risks. II: nature of radiation-induced mutations in experimental mammalian in vivo systems. Mutat. Res. 258 (1991) 51-73
31. Sankaranarayanan K. Ionizing radiation and genetic risks. III: nature of spontaneous and radiation-induced mutations in mammalian in vitro systems and mechanisms of induction of mutations by radiation. Mutat. Res. 258 (1991) 75-97
32. Sankaranarayanan K., and Wassom J. Ionizing radiation and genetic risks XIV. Potential research directions in the post-genome era based on knowledge of repair of radiation-induced DNA double-strand breaks in mammalian somatic cells and the origin of deletions associated with human genomic disorders. Mutat. Res. 578 (2005) 333-370
33. Drake J.W., and Baltz R.H. The biochemistry of mutagenesis. Ann. Rev. Biochem. 45 (1976) 11-37
34. Miller J.H. Mutagenic specificity of ultraviolet light. J. Mol. Biol. 182 (1985) 45-68
35. Glickman B. Study of mutational specificity in the lacl gene of Escherichia coli as a window on the mechanisms of mutation. Environ. Mol. Mutagen. 16 (1990) 48-54
36. Koch W.H., Henrikson E.N., Kupchella E., and Cebula T.A. Salmonella typhimurium strain TA100 differentiates several classes of carcinogens and mutagens by base substitution specificity. Carcinogenesis 15 (1994) 79-88
37. DeMarini D.M. Influence of DNA repair on mutation spectra in Salmonella. Mutat. Res. 450 (2000) 5-17
38. Brash D.E., Rudolph J.A., Simon J.A., Lin A., McKenna G.J., Baden H.P., Halperin A.J., and Ponten J. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 10124-10128
39. Wang F., Saito Y., Shiomi T., Yamada S., Ono T., and Ikehata H. Mutation spectrum in UVB-exposed skin epidermis of a mildly affected XPG-deficient mouse. Environ. Mol. Mutagen. 47 (2006) 107-116
40. Bigger C.A., Ponten I., Page J.E., and Dipple A. Mutational spectra for polycyclic aromatic hydrocarbons in the supF target gene. Mutat. Res. 450 (2000) 75-93
41. Smela M.E., Currier S.S., Bailey E.A., and Essigmann J.M. The chemistry and biology of aflatoxin B(1): from mutational spectrometry to carcinogenesis. Carcinogenesis 22 (2001) 535-545
42. Ripley L.S. Predictability of mutant sequences. Relationships between mutational mechanisms and mutant specificity. Ann. N.Y. Acad. Sci. 870 (1999) 159-172
43. Barnes D.E., and Lindahl T. Repair and genetic consequences of endogenous DNA base damage in mammalian cells. Annu. Rev. Genet. 38 (2004) 445-476
44. Antonarakis S.E., Krawczak M., and Cooper D.N. Disease-causing mutations in the human genome. Eur. J. Pediatr. 159 Suppl. 3 (2000) S173-S178
45. Buzin C.H., Feng J., Yan J., Scaringe W., Liu Q., den Dunnen J., Mendell J.R., and Sommer S.S. Mutation rates in the dystrophin gene: a hotspot of mutation at a CpG dinucleotide. Hum. Mutat. 25 (2005) 177-188
46. Greenblatt M.S., Bennett W.P., Hollstein M., and Harris C.C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54 (1994) 4855-4878
47. Le Calvez F., Mukeria A., Hunt J.D., Kelm O., Hung R.J., Taniere P., Brennan P., Boffetta P., Zaridze D.G., and Hainaut P. TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers. Cancer Res. 65 (2005) 5076-5083
48. Kirk G.D., Lesi O.A., Mendy M., Szymanska K., Whittle H., Goedert J.J., Hainaut P., and Montesano R. 249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma. Oncogene 24 (2005) 5858-5867
49. Bellus, et al. Achondroplasia is defined by recurrent G380R mutations of FGFR3. Am. J. Hum. Genet. 58 (1995) 657-670
50. Wilkie A.O. Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations. Cytokine Growth Factor Rev. 16 (2005) 187-203
51. Pfeifer G.P. Mutagenesis at methylated CpG sequences. Curr. Top. Microbiol. Immunol. 301 (2006) 259-281
52. Deininger P.L., and Batzer M.A. Alu repeats and human disease. Mol. Genet. Metab. 67 (1999) 183-193
53. Bishop A.J.R., and Schiestl R.H. Homologous recombination as a mechanism for genome rearrangements: environmental and genetic effects. Hum. Mol. Genet. 9 (2000) 2427-2434
54. Dubrova Y.E., et al. Mouse minisatellite mutations induced by ionizing radiation. Nat. Genet. 5 (1993) 92-94
55. Bouffler S.D., Bridges B.A., Cooper D.N., Dubrova Y., McMillan T.J., Thacker J., Wright E.G., and Waters R. Assessing radiation-associated mutational risk to the germline: repetitive DNA sequences as Mutational targets and biomarkers. Rad. Res. 165 (2006) 249-268
56. Lambert I.B., et al. Detailed review of transgenic rodent mutation assays. Mutat. Res. 590 (2005) 1-280
57. T.M. Singer, I.B. Lambert, A. Williams, G.R. Douglas, C. M. Yauk, Detection of induced male germline mutation: correlations and comparisons between traditional germline mutation assays, transgenic rodent assays and expanded simple tandem repeat instability assays, Mutat. Res., in press.
58. Winn R. Trangenic fish as models in environmental toxicology. ILAR J. 42 (2001) 322-329
59. Lewis S. Life cycle of the mammalian germ cell: implication for spontaneous mutation frequencies. Teratology 59 (1999) 205-209
60. Hassold T., and Hunt P. To err (meiotically) is human: the genesis of human aneuploidy. Nat. Genet. Rev. 2 (2001) 280-291
61. Yauk C.L., et al. A lacZ transgenic mouse assay for the detection of mutations in follicular granulosa cells. Mutat. Res. 578 (2005) 117e-123e
62. Barnett L.B. Transmission of mutations in the lacI transgene to the offspring of ENU-treated Big Blue male mice. Environ. Mol. Mutagen. 40 (2002) 251-257
63. Rubes J., et al. Smoking cigarettes is associated with increased sperm disomy in teenage men. Fertil. Steril. 70 (1998) 715-723
64. Erickson J.D. Introduction: birth defect surveillance in the United States. Teratology 61 (2000) 1-3
65. Birth defect surveillance data from selected states, 1989-1996. Teratology 61 (2000) 86-158.
66. Ingelman-Sundberg M. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenom. J. 5 (2005) 6-13
67. Iida A., et al. Japanese single nucleotide polymorphism database for 267 possible drug-related genes. Cancer Sci. 97 (2006) 16-24
68. Bosch T.M., Meijerman I., Beijnen J.H., and Schellens J.H. Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer. Clin. Pharmacokinet. 45 (2006) 253-285
69. Rebbeck T.R. Inherited genetic markers and cancer outcomes: personalized medicine in the postgenome era. J. Clin. Oncol. 24 (2006) 1972-1974
70. Wilke R.A., Mustana A.K., and Weber W.W. Cytochrome P450 gene-based drug prescribing and factors impacting translation into routine clinical practice. Personalized Med. 2 (2005) 213-224
71. Ruano G., Makowski G., Windermuth a., Kocherla M., Weiss S., Goethe J.W., Bower B., Wu A.H.B., and Thompson P.D. High carrier prevalence of deficient and null alleles of CYP2 genes in a major US hospital: implications for personalized drug safety. Personalized med. 3 (2006) 131-137
72. Davignon J., Gregg R.E., and Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Atherosclerosis 8 (1988) 1-21
73. Corder E.H., Saunders A.M., Strittmatter W.J., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993) 921-923
74. Corder E.H., Saunders A.M., Risch N.J., et al. Protective effects of apoplipoprotein E type 2 allele for late onset Alzheimer's disease. Nat. Genet. 7 (1994) 180-184
75. Strittmatter W.J., Saunders A.M., Schmechel D., et al. Apolipoprotein E; high avidity binding to beta-amyloid and increased frequency of type 4 allele in late onset familial Alzheimer's disease. Proc. Nat. Acad. Sci. U.S.A. 90 (1993) 1977-1981
76. Goldstein J.L., and Brown M.S. The cholesterol quartet. Science 292 (2001) 1310-1312
77. Spada M., Pagliardini S., Yasuda M., et al. High incidence of later-onset Fabry disease revealed by newborn screening. Am. J. Hum. Genet. 79 (2006) 31-40